title: Aclacinomycin-A in the induction treatment of childhood acute myelogenous leukemia.
authors.forename: F M
authors.initials: FM
authors.lastname: Fink
authors.forename: E R
authors.initials: ER
authors.lastname: Grümayer
authors.forename: G
authors.initials: G
authors.lastname: Kardos
authors.forename: T
authors.initials: T
authors.lastname: Revesz
authors.forename: H
authors.initials: H
authors.lastname: Gadner
authors.forename: D
authors.initials: D
authors.lastname: Schuler
mesh_terms: D015250:Aclarubicin; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D009279:Naphthacenes / Q000008:administration & dosage; D011446:Prospective Studies; D012074:Remission Induction
chemical_list: D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; D003561:Cytarabine; D005047:Etoposide; D015250:Aclarubicin; D003630:Daunorubicin